Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Craig Allred

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotypeDang M Nguyen, Kathy Sam, Anna Tsimelzon, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2006
Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse modelsZhijun Du, Katrina Podsypanina, Shixia Huang, et al.
Molecular and Cellular Biology|October 13, 2006
Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2Robert K Dearth, Xiaojiang Cui, Hyun-Jung Kim, et al.
Breast Cancer Research and Treatment|November 2, 2005
Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancersYee-Lu Tham, L Fernando Gomez, Syed Mohsin, et al.
Breast Cancer Research : BCR|September 9, 2009
An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situFariba Behbod, Frances S Kittrell, Heather LaMarca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24D Craig Allred, Stewart J Anderson, Soonmyung Paik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2005
Neoadjuvant trastuzumab induces apoptosis in primary breast cancersSyed K Mohsin, Heidi L Weiss, M Carolina Gutierrez, et al.
The Journal of Molecular Diagnostics : JMD|December 21, 2016
An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast TumorsJingqin Luo, Shuzhen Liu, Samuel Leung, et al.
Cancer Research|June 17, 2010
PIK3CA mutations in in situ and invasive breast carcinomasAlexander Miron, Maria Varadi, Daniel Carrasco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patientsJenny C Chang, Eric C Wooten, Anna Tsimelzon, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotypeDang M Nguyen, Kathy Sam, Anna Tsimelzon, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2006
Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse modelsZhijun Du, Katrina Podsypanina, Shixia Huang, et al.
Molecular and Cellular Biology|October 13, 2006
Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2Robert K Dearth, Xiaojiang Cui, Hyun-Jung Kim, et al.
Breast Cancer Research and Treatment|November 2, 2005
Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancersYee-Lu Tham, L Fernando Gomez, Syed Mohsin, et al.
Breast Cancer Research : BCR|September 9, 2009
An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situFariba Behbod, Frances S Kittrell, Heather LaMarca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24D Craig Allred, Stewart J Anderson, Soonmyung Paik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2005
Neoadjuvant trastuzumab induces apoptosis in primary breast cancersSyed K Mohsin, Heidi L Weiss, M Carolina Gutierrez, et al.
The Journal of Molecular Diagnostics : JMD|December 21, 2016
An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast TumorsJingqin Luo, Shuzhen Liu, Samuel Leung, et al.
Cancer Research|June 17, 2010
PIK3CA mutations in in situ and invasive breast carcinomasAlexander Miron, Maria Varadi, Daniel Carrasco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patientsJenny C Chang, Eric C Wooten, Anna Tsimelzon, et al.
Pageof 10